Sodium risedronate tablets 17.5 mg “Chemipha” from Nippon Pharmaceutical Industry contains risedronate sodium hydrate in a 17.5 mg tablet (YJ code: 3999019F2243). It is an internal medicine typically used for the management of osteoporosis.
Sodium risedronate tablets 17.5 mg “Chemipha”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
